About Us Links

 

Overview

Team

Consultants

Board of Directors

Board of Advisors

KBL Investments

Contact Us

 

 

 

 

 

 

About Us


Marlene Krauss, M.D.

Chief Executive Officer

marlene

Dr. Marlene Krauss has been our chief executive officer, secretary and a member of our board of directors since our inception. Since November 1998, Dr. Krauss has been a managing member and president of KBL Healthcare Management. During this time, Dr. Krauss co-founded or has served on the board of directors of several of KBL Healthcare Management’s portfolio companies.

Dr. Krauss has also been the chairperson of the board of KBL II since March 2007 and served as its chief executive officer and secretary from its inception in December 2004 until March 2007. From April 1993 to August 1994, Dr. Krauss served as chairperson and chief executive officer of KBL I. In August 1994, upon KBL I’s merger with Concord Health Group, Dr. Krauss continued to serve as the vice chairperson until February 1996.

In August 1991, Dr. Krauss co-founded KBL Healthcare, Inc. and has served as its chairperson and chief executive officer since its formation. In June 1999, Dr. Krauss co-founded Lumenos and has served as a member of its board of directors since its formation. From April 1993 to August 1994, Dr. Krauss served as chairperson and chief executive officer of KBL I. Following its merger with Concord, Dr. Krauss served as the vice chairperson until February 1996. Dr. Krauss also co-founded and/or led the initial financing for the following companies:

  • Candela Corporation, a Nasdaq Global Market listed developer of advanced aesthetic laser systems that allow physicians and personal care practitioners to treat a wide variety of cosmetic and medical conditions;
  • Summit Autonomous Inc., formerly a Nasdaq Global Market listed manufacturer and supplier of excimer laser systems and related products used to perform procedures that correct common refractive vision disorders such as nearsightedness, farsightedness and astigmatism; and
  • Cambridge Heart, Inc., an Over The Counter Bulletin Board listed company that is engaged in the research, development and commercialization of products for the non-invasive diagnosis of cardiac disease.

Dr. Krauss is also a member of the board of directors of PneumRx, Inc., a medical device company developing products for interventional pulmonology applications, of Prolong Pharmaceuticals, a drug delivery company, and of CardioFocus, Inc., an interventional cardio vascular company treating atrial fibrillation.

Dr. Krauss received a B.A. from Cornell University, an M.B.A. from Harvard Graduate School of Business Administration and an M.D. from Harvard Medical School. She trained at the Harvard affiliated hospitals, the Beth Israel Hospital and the Deaconess Hospital, as well as Mt. Sinai Hospital in New York. She completed her training as a vitreoretinal surgeon at New York Hospital in 1985 and was Clinical Instructor of Ophthalmology at New York Hospital and is a Board Certified Ophthalmologist. Dr. Krauss is the wife of Dr. Berk.

Email: mkrauss@kblhealthcare.com Phone: 212-319-5555  ext. 3416

Other team members:
Dr. Zachary Berk, O.D., Chairman
Michael Kaswan, Chief Operating Officer
Eli Berk, Vice President


KBL Healthcare Acquisition Corp. III
380 Lexington Avenue, 31st Fl.
New York, NY 10168
Ph: (212) 319-5555
Fax: (212) 319-5591
Inquiries: inquiries@kblhealthcare.com

 

homeabout usour approachspac overviewinvestorscontact us